ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging

Han, Xue; Yang, Huajing; Jin, Shiyang; Sun, Yunfeng; Zhang, Hongxia; Shan, Ming; Cheng, Wen*哈尔滨医科大学
Cancer Medicine2023-1DOI: 10.1002/cam4.5019
1被引6阅读
引用收藏
分享

摘要

This study aimed to evaluate the value of dynamic contrast-enhanced ultrasound (CEUS) combined with dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in predicting pathological complete response (pCR) in patients with breast cancer receiving neoadjuvant chemotherapy (NAC). Fifty-seven female patients with breast cancer (mean age, 50.46 years; range, 32-66 years) scheduled for NAC were recruited. CEUS and DCE-MRI were performed before and after NAC. Imaging features and their changes were compared with postoperative pathological results. After the clinical differences were balanced using propensity score matching, univariate and multiple logistic regression analyses were used to derive the characteristics independently associated with pCR. Receiver operating characteristic curve analysis was performed to assess diagnostic performance. After six to eight cycles of NAC, 24 (42.1%) patients achieved pCR, while 33 (57.9%) did not. Multivariate analysis showed that enhancement order on CEUS and DCE-MRI before NAC, reduction in diameter and enhancement shape on CEUS, maximum diameter on DCE-MRI, and the type of progressive dynamic contrast enhancement after NAC were independently associated with pCR after NAC. The area under the receiver operating characteristic curve for CEUS+DCE-MRI was 0.911 (95% confidence interval, 0.826-0.997), and the specificity and positive predictive values were 87.0% and 87.5%. CEUS and DCE-MRI have the potential for assessing the pathological response to NAC in patients with breast cancer; their combination showed the best diagnostic performance. CEUS+DCE-MRI has proved beneficial for comprehensive assessment and personalizing treatment strategies for patients with breast cancer.

学科与关键词

关键词
contrast-enhanceddynamic contrast-enhanced MRIneoadjuvant chemotherapyultrasoundultrasound breast cancer
相关
加载中…
  • Early Prediction of Response to Neoadjuvant Chemotherapy Using Quantitative Parameters on Automated Breast Ultrasound Combined with Contrast-Enhanced Ultrasound in Breast Cancer
    Xie, Yongwei; Chen, Yu; Wang, Qiucheng; Li, Bo; Shang, Haitao; Jing, Hui*Ultrasound in Medicine and Biology, 2023, 49(7): 1638-1646.被引 1
  • Radiomics Based on DCE-MRI for Predicting Response to Neoadjuvant Therapy in Breast Cancer
    Zeng, Qiao; Xiong, Fei; Liu, Lan; Zhong, Linhua; Cai, Fengqin; Zeng, Xianjun*ACADEMIC RADIOLOGY, 2023, 30 Suppl 2: S38-S49.
  • MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer
    Shi, Zhenwei; Huang, Xiaomei; Cheng, Ziliang; Xu, Zeyan; Lin, Huan; Liu, Chen; Chen, Xiaobo; Liu, Chunling; Liang, Changhong; Lu, Cheng; Cui, Yanfen; Han, Chu; Qu, Jinrong; Shen, Jun; Liu, Zaiyi*RADIOLOGY, 2023, 308(1): e222830.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Medicine
发表日期
2023-01
卷期
第 12 卷, 第 2 期
页码
1389-1398
DOI
10.1002/cam4.5019
语言
ENGLISH
成果收录
SCIE

作者

  • H

    Han, Xue (第一作者)

    harbin med univ

  • Y

    Yang, Huajing

    harbin med univ

查看全部 7 位作者收起作者
  • J

    Jin, Shiyang

    harbin med univ

  • S

    Sun, Yunfeng

    harbin med univ

  • Z

    Zhang, Hongxia

    harbin med univ

  • S

    Shan, Ming

    harbin med univ

  • C

    Cheng, Wen (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417